JSC Retinoids Launches Unique Pharmaceutical Birch Tar Production in Balashikha
JSC Retinoids has organized the production of pharmaceutical-grade purified...
Production of the Russian Smallpox Drug “NIOCH-14” May Start in the Spring of 2026
This is the first chemical drug in Russia intended for the treatment and emergency prevention of smallpox and other orthopoxvirus infections, including mpox.
R-Pharm Import-Substitutes German Erbitux — Drug for Head and Neck Cancer Therapy
The Ministry of Health of the Russian Federation has...
Petrovax Pharm Investments in Meningitis Vaccine Production Exceed 3 Billion Rubles
Biopharmaceutical company Petrovax Pharm has announced receiving an expanded...
Ellara Prepares to Launch Unique Peptide Synthesis Facility
Pharmaceutical company Ellara is completing preparations for the opening...
Big Pharma 2025: Biggest Winners, New Leaders, and Major Drops in the Top 20 Rankings
The worldwide pharmaceutical industry has summarized its financial results...
Strategic Alliance Between Novo Nordisk and OpenAI: AI to Accelerate Drug Development
Danish pharmaceutical giant Novo Nordisk has officially announced a...
CapVest Closes Deal to Acquire Controlling Stake in STADA
International investment firm CapVest Partners has officially announced the...
Eli Lilly to Acquire Centessa Pharmaceuticals for $7.8 Billion to Advance Sleep Disorders Portfolio
Pharmaceutical corporation Eli Lilly has announced a definitive agreement...
EMA Publishes GMDP Inspectors Work Plan for 2026–2028: Focus on AI, Supply Chain Protection, and Global Partnership
The European Medicines Agency (EMA) has presented the three-year...
Minpromtorg to Compensate Pharma Companies for Clinical Trial Costs Starting in 2027
The Ministry of Industry and Trade of the Russian...
State Duma Finally Approves Law on Mobile Pharmacies
The State Duma of the Russian Federation has adopted...
Russia Simplifies Market Entry for New Veterinary Vaccines: Notification Procedure Established
The Government of the Russian Federation has decided to...
Changes to the EAEU GMP Rules: Updated Requirements for the Manufacture of Sterile Medicinal Products
On April 14, 2026, the EEC Board adopted Resolution...
Ministry of Health Introduces Special Procedure for Individual Gene Therapy
The Ministry of Health of the Russian Federation has...
Strategic Alliance Between Novo Nordisk and OpenAI: AI to Accelerate Drug Development
Danish pharmaceutical giant Novo Nordisk has officially announced a...
AI and Billion-Dollar Investments: Eli Lilly Signs an Agreement with Insilico Medicine Worth Up to $2.75 Billion
American pharmaceutical giant Eli Lilly continues to actively invest in artificial intelligence technologies and biotechnological developments.
Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma
On February 25, 2026, pharmaceutical giant Eli Lilly officially...
An “AI Pill” for Indian Pharma: Sun Pharma and Glenmark Change the Rules of the Game
The Indian pharmaceutical industry, long known as the "pharmacy of the world" due to its generic drug production, is beginning a technological transformation.
SUSU Scientists Synthesize a Selective Anti-Anxiety Molecule
Researchers at South Ural State University (SUSU) have discovered...
JSC Retinoids Launches Unique Pharmaceutical Birch Tar Production in Balashikha
JSC Retinoids has organized the production of pharmaceutical-grade purified...
Production of the Russian Smallpox Drug “NIOCH-14” May Start in the Spring of 2026
This is the first chemical drug in Russia intended for the treatment and emergency prevention of smallpox and other orthopoxvirus infections, including mpox.
R-Pharm Import-Substitutes German Erbitux — Drug for Head and Neck Cancer Therapy
The Ministry of Health of the Russian Federation has...
Petrovax Pharm Investments in Meningitis Vaccine Production Exceed 3 Billion Rubles
Biopharmaceutical company Petrovax Pharm has announced receiving an expanded...
Ellara Prepares to Launch Unique Peptide Synthesis Facility
Pharmaceutical company Ellara is completing preparations for the opening...
Big Pharma 2025: Biggest Winners, New Leaders, and Major Drops in the Top 20 Rankings
The worldwide pharmaceutical industry has summarized its financial results...
Strategic Alliance Between Novo Nordisk and OpenAI: AI to Accelerate Drug Development
Danish pharmaceutical giant Novo Nordisk has officially announced a...
CapVest Closes Deal to Acquire Controlling Stake in STADA
International investment firm CapVest Partners has officially announced the...
Eli Lilly to Acquire Centessa Pharmaceuticals for $7.8 Billion to Advance Sleep Disorders Portfolio
Pharmaceutical corporation Eli Lilly has announced a definitive agreement...
EMA Publishes GMDP Inspectors Work Plan for 2026–2028: Focus on AI, Supply Chain Protection, and Global Partnership
The European Medicines Agency (EMA) has presented the three-year...
Minpromtorg to Compensate Pharma Companies for Clinical Trial Costs Starting in 2027
The Ministry of Industry and Trade of the Russian...
State Duma Finally Approves Law on Mobile Pharmacies
The State Duma of the Russian Federation has adopted...
Russia Simplifies Market Entry for New Veterinary Vaccines: Notification Procedure Established
The Government of the Russian Federation has decided to...
Changes to the EAEU GMP Rules: Updated Requirements for the Manufacture of Sterile Medicinal Products
On April 14, 2026, the EEC Board adopted Resolution...
Ministry of Health Introduces Special Procedure for Individual Gene Therapy
The Ministry of Health of the Russian Federation has...
Strategic Alliance Between Novo Nordisk and OpenAI: AI to Accelerate Drug Development
Danish pharmaceutical giant Novo Nordisk has officially announced a...
AI and Billion-Dollar Investments: Eli Lilly Signs an Agreement with Insilico Medicine Worth Up to $2.75 Billion
American pharmaceutical giant Eli Lilly continues to actively invest in artificial intelligence technologies and biotechnological developments.
Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma
On February 25, 2026, pharmaceutical giant Eli Lilly officially...
An “AI Pill” for Indian Pharma: Sun Pharma and Glenmark Change the Rules of the Game
The Indian pharmaceutical industry, long known as the "pharmacy of the world" due to its generic drug production, is beginning a technological transformation.
SUSU Scientists Synthesize a Selective Anti-Anxiety Molecule
Researchers at South Ural State University (SUSU) have discovered...
PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).
Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.
Headlines
Review of scheduled, unscheduled, and foreign GMP inspections of pharmaceutical production facilities (June 2026)
This analytical review is based on official data obtained...
Experts continue to discuss possible changes to the regulations governing veterinary drugs in the EAEU
On June 23, a working meeting of experts was...
GMP Registry Update: 7 New Certificates and 2 Refusals in Late April 2026
The Ministry of Industry and Trade of the Russian...
Dmitry Kudlay: Russian Technologies Break Into the Global Stage But Stall in Public Procurement
Russian pharmaceutical science has reached a level where innovative...
